Unichem Laboratories share price
You have to be logged in to add this to Watchlist.- ₹370.05(-2.25%)January 23, 2026 15:27:55 PM IST
- NSE
- BSE
- Vol : 9.77 K (NSE + BSE)Last 20 day avg : 13.96 K
Unichem Laboratories is trading -2.25% lower at Rs 370.05 as compared to its last closing price. Unichem Laboratories has been trading in the price range of 382.70 & 369.85. Unichem Laboratories has given -13.98% in this year & -8.19% in the last 5 days. Unichem Laboratories has TTM P/E ratio 36.73 as compared to the sector P/E of 22.37.The company posted a net profit of -11.89 Crores in its last quarter.Listed peers of Unichem Laboratories include Themis Medicare (-2.89%), Pfizer (-2.86%), Jagsonpal Pharmaceuticals (-0.30%).The Mutual Fund holding in Unichem Laboratories was at 9.17% in 31 Dec 2025. The MF holding has decreased from the last quarter. The FII holding in Unichem Laboratories was at 0.99% in 31 Dec 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Jan 24, 2026, 10:10 PM UTC
- BetaLow volatility0.59Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.19The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BIn line with historical values1.09The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values30.37Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation0.50The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Themis Medicare | Bearish | 79.00 | -2.89 | 728.48 | 31.81 | 2.35 | 0.49 | 4.62 |
| Pfizer | Bearish | 4,588.20 | -2.86 | 21,016.90 | 36.12 | 5.46 | 0.69 | 1.60 |
| Jagsonpal Pharmaceuticals | Bearish | 164.45 | -0.30 | 1,096.23 | 33.88 | 5.54 | 1.25 | 3.18 |
| Aurobindo Pharma | Bearish | 1,133.15 | -1.09 | 65,836.52 | 20.15 | 2.15 | 0.33 | 5.52 |
| Neuland Laboratories | Bearish | 13,360.00 | -1.85 | 17,280.12 | 92.96 | 12.69 | 0.08 | 7.17 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-02-05 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-04 | Quarterly Results |
| 2025-05-22 | Audited Results |
| 2025-02-06 | Quarterly Results |
- IndustryMajor Drugs
- ISININE351A01035
- BSE Code506690
- NSE CodeUNICHEMLAB
Unichem Laboratories is trading at 370.05 as on Fri Jan 23 2026 09:57:55. This is -2.25% lower as compared to its previous closing price of 378.55.
The market capitalization of Unichem Laboratories is 2605.37 Cr as on Fri Jan 23 2026 09:57:55.
The 52 wk high for Unichem Laboratories is 785.85 whereas the 52 wk low is 374.25
Unichem Laboratories can be analyzed on the following key metrics -
- TTM P/E: 36.73
- Sector P/E: 22.37
- Dividend Yield: 0.00%
- D/E ratio: 0.21
Unichem Laboratories reported a net profit of 137.52 Cr in 2025.
The Mutual Fund Shareholding was 9.17% at the end of 31 Dec 2025.
EQUITY QUICK LINKS
Unichem Laboratories QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.